All Rights Reserved This Work by Wilolud Journals Is Licensed under a Creative Commons Attribution 3.0 Unported License Epidemiology and Clinical Spectrum of Cutaneous Diseases Manifesting among Newly Diagnosed Hiv Seropositive Adults in Nakuru County-kenya

Ramadhan L. Mawenzi,Onyango R Oguttu,H. Williams,Aluoch Joash
Abstract:Background. The skin is exceptionally vulnerable to various diseases in people with human immunodeficiency virus (HIV) infection. The prevalence of skin diseases in HIV varies by country and region. In Kenya, the prevalence, patterns and distribution of HIV-related skin diseases is unknown. Estimating the burden of HIV-related skin morbidity is important in planning skin care for HIV patients in any given community. It is necessary therefore to conduct such studies in Kenya. Method. We conducted a cross-sectional survey of 394 newly diagnosed HIV seropositive patients seeking care at the HIV comprehensive care centre in Rift Valley Provincial Hospital. All patients were examined for skin diseases by two dermatologists for diagnostic concurrence. Their CD4 cell counts were analysed by the centre's laboratory technologist using Fluorescence-Activated Cell Sorter (FACS) system. Results. Women outnumbered men by 1.9:1. The overall mean age was 36.5 years (SD±9.69) and the mean CD4 cell count was 251.7cells/mm 3 (SD±261.05). 42% (166/394) of the patients presented with one or more skin diseases. Oral thrush (6.3%), pruritic papular eruption (5%), seborrheic dermatitis (4.8%), eczema (4.3%), herpes zoster (3.6%), xerosis (2.8%) and vaginal candidiasis (2.8%) were the leading diseases. Oral thrush (p<.019), pruritic papular eruption (p<.012) and seborrheic dermatitis (p<.001) were the only diseases with a significant correlation with lower CD4 cell counts. Conclusion. Skin diseases remain common among newly diagnosed adults with HIV in Nakuru County. Most of those with skin disease are severely immunodepressed and eligible for commencement of anti-retroviral therapy. INTRODUCTION The pathologic relationship between human immunodeficiency virus (HIV) and the skin starts at seroconversion and intensifies as the CD4 cell population is progressively decimated by the virus (Cedeno-Laurent et al., 2011). The skin is therefore the first and the most universally afflicted organ in the course of HIV infection (Singh et al., 2009; Queiroz-Zancanaro et al., 2006). Determining the burden of skin diseases among HIV patients and estimating their CD4 cell counts as well as viral loads where applicable, are therefore important components in the management of HIV related skin diseases (Jung and Paauw 1998; Ghate et al., 2000). However, in underprivileged nations where expensive laboratory investigations cannot be readily afforded or conducted pronto, certain skin diseases have been used to predict initial HIV infection and immune status of most patients (Ghate et al., 2000).
What problem does this paper attempt to address?